Silvia Picciolini graduated in pharmaceutical chemistry and technologies (CTF) at the University of Milan on March 2014. She spent one year at FDG doing research experience for her experimental thesis in collaboration with a spin off of the Joint Research Centre (Ispra) aimed at the optimization of nanohole arrays as solid SERS substrates for the detection of genetic biomarkers of acute myeloid leukemia, to evaluate the minimal residual disease. She was granted with an AXA scholarship for the Raman analysis of lipids in the blood of Alzheimer’s patients. In 2019, she has completed her PhD in Translational and Molecular Medicine at University of Milano-Bicocca working at LABION on a  project aimed at the detection and characterization of neural extracellular vesicles from human plasma by a SPRi based biosensor, in order to identify their role in the pathogenesis of Alzheimer’s disease. Now, she is applying the optimized SPRi platform for the rehabilitation monitoring of stroke and heart failure patients. She worked also on the biophotonics characterization of liposomes as therapeutic agents for neurological diseases (NEVERMIND project). She is co-author of several publications in international peer-reviewed journals and abstracts of national and international conferences.

Email: spicciolini@dongnocchi.it